Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
December 14, 2018 - Teva and Celltrion announced the FDA approval of Herzuma (trastuzumab-pkrb), a biosimilar to Genentech’s Herceptin® (trastuzumab).
Download PDF
Return to publications
